|
Index of reports
> Serious Reactions (917)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cytarabine serious reactions. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 917 Next >>
Possible Cytarabine side effects in female
Reported by a physician from Japan on 2012-08-27
Patient: female, weighing 45.8 kg (100.8 pounds)
Reactions: Cerebral Haemorrhage
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Cisplatin
Dosage: 100mgm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-11
Cytarabine
Dosage: 4gm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-12
Dexamethasone
Dosage: 40mg every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-11
Ofatumumab
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-08
Other drugs received by patient: Granisetron; Maglax; Primperan TAB; Rabeprazole Sodium; Orgadrone
Possible Cytarabine side effects in male
Reported by a physician from Germany on 2012-08-24
Patient: male, weighing 95.8 kg (210.8 pounds)
Reactions: Abdominal Pain, Hypotension, Pancytopenia, Ascites, Faecaloma, Diarrhoea, Sepsis, Colitis, Septic Shock
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 25 mg/m2, unk
Start date: 2012-07-31
End date: 2012-08-04
Clofarabine
Dosage: 25 mg/m2, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-29
End date: 2012-07-03
Cytarabine
Dosage: 750 mg/m2, unk
Start date: 2012-07-31
End date: 2012-08-04
Cytarabine
Dosage: 750 mg/m2, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-29
End date: 2012-07-03
Idarubicin HCL
Dosage: 7.5 mg/m2, unk
Start date: 2012-07-31
End date: 2012-08-02
Idarubicin HCL
Dosage: 7.5 mg/m2, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-29
End date: 2012-07-01
Other drugs received by patient: Vancomycin; Metronidazole; Piritramide; Enoxaparin Sodium; Zofran; Clonazepam; Sodium Chloride; Ciprofloxacin; Acyclovir; Ringer; Levothyroxine Sodium; Potassium Chloride; Ceftazidime; Noxafil
Possible Cytarabine side effects in
Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-08-24
Patient:
Reactions: Radiculopathy
Drug(s) suspected as cause:
Cisplatin
Indication: Diffuse Large B-Cell Lymphoma
Cytarabine
Indication: Diffuse Large B-Cell Lymphoma
Dexamethasone
Indication: Diffuse Large B-Cell Lymphoma
Mabthera
Indication: Diffuse Large B-Cell Lymphoma
Possible Cytarabine side effects in 17 year old male
Reported by a consumer/non-health professional from United States on 2012-08-23
Patient: 17 year old male, weighing 89.9 kg (197.8 pounds)
Reactions: Pharyngeal Inflammation, Hypoxia, Caecitis, Rash Maculo-Papular, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cefepime
Indication: Acute Myeloid Leukaemia
Cytarabine
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-05-28
Cytarabine
Dosage: unk
Start date: 2012-05-18
End date: 2012-05-18
Daunorubicin HCL
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-05-22
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-05-22
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-05-26
Possible Cytarabine side effects in
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-23
Patient:
Reactions: Cardio-Respiratory Arrest
Adverse event resulted in: death
Drug(s) suspected as cause:
Cytarabine
Dosage: 200 mg, once
Start date: 2012-02-22
End date: 2012-02-22
Emend
Dosage: 125 mg, once
Administration route: Oral
Start date: 2012-02-21
End date: 2012-02-21
Emend
Dosage: 80 mg, once
Administration route: Oral
Start date: 2012-02-22
End date: 2012-02-22
Etoposide
Dosage: 200 mg, once
Start date: 2012-02-22
End date: 2012-02-22
Methylprednisolone
Dosage: 160 mg, once
Start date: 2012-02-22
End date: 2012-02-22
Methylprednisolone
Dosage: 60 mg, once
Start date: 2012-02-21
End date: 2012-02-21
Ondansetron
Dosage: 8 mg, once
Start date: 2012-02-21
End date: 2012-02-21
Ondansetron
Dosage: 8 mg, once
Start date: 2012-02-22
End date: 2012-02-22
Other drugs received by patient: Bicnu; Diamicron; Pravastatin Sodium; Amlodipine; Valium; Nexium; Tramadol HCL; Acetaminophen
Possible Cytarabine side effects in
Reported by a physician from United States on 2012-08-22
Patient:
Reactions: Abdominal Pain, Thrombosis, Hyperkalaemia, Coagulopathy, Hypoglycaemia, Hypocalcaemia, Hypoxia, Hiccups, Alanine Aminotransferase Abnormal, Pneumonitis, Cough, Pain in Extremity, Hypotension, Hyperglycaemia, External Ear Pain, Haematotoxicity, Dehydration, Lower Gastrointestinal Haemorrhage, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Hypokalaemia, Blood Bilirubin Abnormal, Pleural Effusion, Decreased Appetite, Gamma-Glutamyltransferase Abnormal, Hyponatraemia, Hypercalcaemia, Hypophosphataemia, Diarrhoea, Hypoalbuminaemia, Hypertension, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin HCL
Dosage: given over 15-30 minutes on day 1
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Methotrexate Sodium
Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Vancomycin; Posaconazole; Voriconazole; Levofloxacin
Possible Cytarabine side effects in 54 year old female
Reported by a health professional (non-physician/pharmacist) from Spain on 2012-08-22
Patient: 54 year old female
Reactions: Osteomyelitis, Febrile Neutropenia, Osteonecrosis, Bacterial Disease Carrier, Face Oedema, Osteonecrosis of JAW, Endocarditis Enterococcal, Bone Marrow Failure, Candidiasis, Purulent Discharge, Pain in JAW
Drug(s) suspected as cause:
Cytarabine
Dosage: 200 mg/m2, unk
Indication: Acute Myeloid Leukaemia
Cytarabine
Dosage: 3 g/m2 every 12 hours for 4 days
Daunorubicin HCL
Dosage: 45 mg/m2, unk
Indication: Acute Myeloid Leukaemia
Idarubicin HCL
Dosage: 12 mg/m2, unk
Indication: Acute Myeloid Leukaemia
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-08-21
Patient: female, weighing 108.0 kg (237.6 pounds)
Reactions: Blood Alkaline Phosphatase Increased, Bronchopulmonary Aspergillosis, Haemoptysis, Tinea Cruris, Haemorrhage Intracranial, Transfusion Reaction, Constipation, Mucosal Inflammation, Oesophageal Candidiasis, Respiratory Failure, Diarrhoea, Oral Candidiasis, Sepsis, Blood Creatinine Increased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 1000 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Etoposide
Dosage: 100 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Mitoxantrone
Dosage: 8 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Mozobil
Dosage: 560 mcg/kg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-19
End date: 2012-02-24
Other drugs received by patient: Omeprazole; Oxycontin; Neupogen; Multi-Vitamin; Biotene; Oxycodone HCL; Platelets; Acyclovir; Albuterol; Allopurinol; Carvedilol; Hydroxyurea; Docusate; Spiriva; Bactrim
Possible Cytarabine side effects in 51 year old female
Reported by a health professional (non-physician/pharmacist) from Hong Kong on 2012-08-21
Patient: 51 year old female
Reactions: Granulocytopenia, Palmar-Plantar Erythrodysaesthesia Syndrome, Staphylococcal Sepsis
Adverse event resulted in: death
Drug(s) suspected as cause:
Clofarabine
Dosage: 40 mg/m2, qd
Indication: Acute Myeloid Leukaemia Recurrent
Cytarabine
Dosage: 1 g/m2, qd
Indication: Acute Myeloid Leukaemia Recurrent
Possible Cytarabine side effects in 14 year old male
Reported by a physician from Norway on 2012-08-21
Patient: 14 year old male, weighing 75.0 kg (165.0 pounds)
Reactions: Mucosal Inflammation, Listless, Fatigue, Febrile Neutropenia, Sinusitis, Decreased Appetite
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Celecoxib
Dosage: 400 mg, 2x/day
Indication: Medulloblastoma
Cytarabine
Dosage: 50 mg, cyclic, every other month
Cytarabine
Dosage: 50 mg, cyclic, every other week then monthly
Indication: Medulloblastoma
Etoposide
Dosage: 100 mg, 1x/day
Administration route: Oral
Indication: Medulloblastoma
Thalidomide
Dosage: 200 mg, 1x/day
Administration route: Oral
Indication: Medulloblastoma
Other drugs received by patient: Prednisolone Succinate
Possible Cytarabine side effects in
Reported by a physician from United States on 2012-08-20
Patient:
Reactions: Adrenal Insufficiency, Encephalopathy
Drug(s) suspected as cause:
Cytarabine
Dosage: unk unk, cyclic
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2, cyclic
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: 60 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: unk, cyclic
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: unk, cyclic
Indication: Acute Lymphocytic Leukaemia
PEG-Asparaginase
Dosage: unk, cyclic
Indication: Acute Lymphocytic Leukaemia
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Possible Cytarabine side effects in
Reported by a physician from United States on 2012-08-20
Patient:
Reactions: Abdominal Pain, Thrombosis, Hyperkalaemia, Hypoglycaemia, Coagulopathy, Hypokalaemia, Blood Bilirubin Abnormal, Hiccups, Pleural Effusion, Hypoxia, Hypocalcaemia, Alanine Aminotransferase Abnormal, Cough, Pneumonitis, Decreased Appetite, Pain in Extremity, Hypotension, Hyperglycaemia, Gamma-Glutamyltransferase Abnormal, Hyponatraemia, External Ear Pain, Hypercalcaemia, Haematotoxicity, Hypophosphataemia, Diarrhoea, Dehydration, Hypoalbuminaemia, Lower Gastrointestinal Haemorrhage, Hypertension, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: given over 15-30 minutes on day 1
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Levofloxacin; Voriconazole; Posaconazole; Vancomycin
Possible Cytarabine side effects in male
Reported by a consumer/non-health professional from Netherlands on 2012-08-20
Patient: male, weighing 76.0 kg (167.2 pounds)
Reactions: Hepatic Function Abnormal, Splenic Embolism, Encephalopathy, Febrile Neutropenia, Pneumonia Cytomegaloviral, Mucosal Inflammation, Enterococcal Sepsis, Pericarditis, Cerebral Artery Embolism, Respiratory Failure, Ventricular Tachycardia, Acute Respiratory Distress Syndrome, Renal Failure Acute, Candidiasis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 19.6 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-04-01
Cytarabine
Dosage: 391 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-04-03
Idarubicin HCL
Dosage: 23.5 mg, unk
Indication: Acute Leukaemia
Start date: 2012-03-28
End date: 2012-03-30
Possible Cytarabine side effects in 17 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-20
Patient: 17 year old female, weighing 42.7 kg (93.9 pounds)
Reactions: Flushing, Oral Pain, Skin Exfoliation, Pain of Skin, Peripheral Sensory Neuropathy
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Cytarabine
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-09
End date: 2012-07-17
Daunorubicin HCL
Dosage: unk
Indication: Acute Myeloid Leukaemia
Doxorubicin Hydrochloride
Dosage: 50 mg/m2, cyclic
Start date: 2012-06-09
End date: 2012-07-14
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-09
End date: 2012-07-14
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-09
End date: 2012-07-17
Possible Cytarabine side effects in
Reported by a physician from United States on 2012-08-20
Patient:
Reactions: Off Label Use, Zygomycosis
Drug(s) suspected as cause:
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Indication: Acute Lymphocytic Leukaemia
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15,22 for cns invlovment
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15,22 for cns invlovment
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15,22 for cns invlovment
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15,22 for cns invlovment
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 24 consecutive days
Administration route: Oral
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 24 consecutive days
Administration route: Oral
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 24 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 24 consecutive days
Administration route: Oral
Doxorubicin Hydrochloride
Dosage: given over 15-30 minutes on day 1
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: given over 15-30 minutes on day 1
Doxorubicin Hydrochloride
Dosage: given over 15-30 minutes on day 1
Doxorubicin Hydrochloride
Dosage: given over 15-30 minutes on day 1
Hydrocortisone
Dosage: on days 8, 15 and 22
Hydrocortisone
Dosage: on days 8, 15 and 22
Hydrocortisone
Dosage: on days 8, 15 and 22
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: 1 dose on day 15 for no cns invlovement and on days 8, 15, 22 for cns invlovement
Methotrexate
Dosage: 1 dose on day 15 for no cns invlovement and on days 8, 15, 22 for cns invlovement
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: 1 dose on day 15 for no cns invlovement and on days 8, 15, 22 for cns invlovement
Methotrexate
Dosage: 1 dose on day 15 for no cns invlovement and on days 8, 15, 22 for cns invlovement
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Possible Cytarabine side effects in
Reported by a physician from United States on 2012-08-20
Patient:
Reactions: Gastrointestinal Haemorrhage, Coagulopathy, Escherichia Sepsis
Drug(s) suspected as cause:
Cytarabine
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2, cyclic
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: 60 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Indication: Acute Lymphocytic Leukaemia
PEG-Asparaginase
Dosage: unk, cyclic
Indication: Acute Lymphocytic Leukaemia
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Possible Cytarabine side effects in female
Reported by a physician from United States on 2012-08-20
Patient: female, weighing 70.8 kg (155.8 pounds)
Reactions: Abdominal Pain, Hyperpyrexia, Anaphylactic Reaction, Chills, Pain, Hepatic Failure, Transaminases Increased, Splenic Infarction, Loss of Consciousness, Aortic Thrombosis, Off Label Use, Malaise, C-Reactive Protein Increased, Myositis, Dyspnoea, Hypotension, Arrhythmia, Lung Consolidation, Hypophosphataemia, Zygomycosis, Bacteraemia, Ventricular Tachycardia, Hyperammonaemia, Neutropenia, Hepatic Infarction, Shock, Infusion Related Reaction
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Cytarabine
Dosage: day 1,8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
Decadron Phosphate
Dosage: day 1
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
Doxil
Dosage: day 1
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Methotrexate
Dosage: day 1
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-01-01
End date: 2007-01-01
PEG-Asparaginase
Dosage: day 2, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-25
End date: 2007-10-25
Velcade
Dosage: day 1, 4, 8 and 11
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Vincristine
Dosage: day 1,8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Possible Cytarabine side effects in 44 year old male
Reported by a physician from Germany on 2012-08-17
Patient: 44 year old male, weighing 80.0 kg (176.0 pounds)
Reactions: Pneumonia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 200 mg, daily
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-06
End date: 2012-06-12
Etoposide
Dosage: 200 mg, daily
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-06
End date: 2012-06-08
Gemtuzumab Ozogamicin
Dosage: 6 mg, 1x/day
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-06
End date: 2012-06-06
Idarubicin HCL
Dosage: 24 mg, daily
Start date: 2012-06-08
End date: 2012-06-08
Idarubicin HCL
Dosage: 24 mg, daily
Start date: 2012-06-10
End date: 2012-06-10
Idarubicin HCL
Dosage: 24 mg, daily
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-06
End date: 2012-06-06
Tretinoin
Dosage: 90 mg, daily
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-11
End date: 2012-06-12
Tretinoin
Dosage: 30 mg, daily
Start date: 2012-06-13
End date: 2012-06-16
Tretinoin
Dosage: 30 mg, daily
Start date: 2012-06-21
End date: 2012-06-21
Possible Cytarabine side effects in
Reported by a physician from United States on 2012-08-17
Patient:
Reactions: Off Label Use, Hypoxia, Bacterial Sepsis
Drug(s) suspected as cause:
Bortezomib
Dosage: push on days 1, 4, 8, and 11
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: day 1 with no cns involvement + on days 8, 15 + 22 with cns involvement
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: divided into 2 doses for 14 consecutive days from day 1
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: over 15-30 minutes on day 1
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: who had no cns involvement- day 15;
Indication: Acute Lymphocytic Leukaemia
PEG-Asparaginase
Dosage: pegylated 2500 units/m2/dose given intravenously as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: by push (2 mg maximum dose) was administered intravenously by push day 1, 8, 15, and 22
Indication: Acute Lymphocytic Leukaemia
Possible Cytarabine side effects in 44 year old female
Reported by a physician from France on 2012-08-17
Patient: 44 year old female
Reactions: Lung Disorder, Gastrointestinal Haemorrhage, Mesenteric Panniculitis, Sepsis, Febrile Bone Marrow Aplasia
Drug(s) suspected as cause:
Cytarabine
Dosage: 348 mg, 1x/day
Indication: Acute Leukaemia
Start date: 2008-07-22
End date: 2008-07-28
Daunorubicin HCL
Dosage: 104.4 mg, 1x/day
Indication: Acute Leukaemia
Start date: 2008-07-22
End date: 2008-07-24
Mylotarg
Dosage: 10.4 mg, 1x/day
Indication: Acute Leukaemia
Start date: 2008-07-25
End date: 2008-07-25
Possible Cytarabine side effects in male
Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-08-17
Patient: male, weighing 68.0 kg (149.6 pounds)
Reactions: Dyspnoea, Vomiting, Nausea, Hyperreflexia, Encephalopathy, Extensor Plantar Response, Endophthalmitis, Lung Consolidation, Respiratory Failure, Emotional Disorder, CSF Pressure Increased, Reflexes Abnormal, Lethargy
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Amsacrine
Dosage: 220 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-28
Clofarabine
Dosage: 18 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-25
Cytarabine
Dosage: 3600 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-25
Other drugs received by patient: Valaciclovir
Possible Cytarabine side effects in
Reported by a physician from United States on 2012-08-17
Patient:
Reactions: Off Label Use, Zygomycosis
Drug(s) suspected as cause:
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15,22 for cns invlovment
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15,22 for cns invlovment
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15,22 for cns invlovment
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15,22 for cns invlovment
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 24 consecutive days
Administration route: Oral
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 24 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 24 consecutive days
Administration route: Oral
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 24 consecutive days
Administration route: Oral
Doxorubicin Hydrochloride
Dosage: given over 15-30 minutes on day 1
Doxorubicin Hydrochloride
Dosage: given over 15-30 minutes on day 1
Doxorubicin Hydrochloride
Dosage: given over 15-30 minutes on day 1
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: given over 15-30 minutes on day 1
Hydrocortisone
Dosage: on days 8, 15 and 22
Hydrocortisone
Dosage: on days 8, 15 and 22
Hydrocortisone
Dosage: on days 8, 15 and 22
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: 1 dose on day 15 for no cns invlovement and on days 8, 15, 22 for cns invlovement
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: 1 dose on day 15 for no cns invlovement and on days 8, 15, 22 for cns invlovement
Methotrexate
Dosage: 1 dose on day 15 for no cns invlovement and on days 8, 15, 22 for cns invlovement
Methotrexate
Dosage: 1 dose on day 15 for no cns invlovement and on days 8, 15, 22 for cns invlovement
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Possible Cytarabine side effects in 63 year old female
Reported by a physician from Germany on 2012-08-17
Patient: 63 year old female, weighing 49.0 kg (107.8 pounds)
Reactions: Pneumonia Cryptococcal, Cardiac Failure, Mitral Valve Incompetence, Bone Marrow Failure, Acute Myocardial Infarction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: sequential high dose, sham regimen, within amlcg-2008 study
Indication: Acute Myeloid Leukaemia
Mitoxantrone
Dosage: sequential high dose, sham regimen, within amlcg-2008 study
Indication: Acute Myeloid Leukaemia
Possible Cytarabine side effects in
Reported by a physician from United States on 2012-08-16
Patient:
Reactions: Off Label Use, Amylase Abnormal, Lipase Abnormal
Drug(s) suspected as cause:
Bortezomib
Dosage: per dose on days 1, 4, 8 and 11
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 or days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: divided into 2 doses was given orally for 14 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: over 15-30 minutes on day 1
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: on day 15 or days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
PEG-Asparaginase
Dosage: 2500 units/m2/dose was given intramuscularly as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: per dose (2 mg maximum dose) was administered intravenously by push on day 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Voriconazole; Vancomycin; Levofloxacin; Posaconazole
Possible Cytarabine side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-16
Patient: female, weighing 87.8 kg (193.2 pounds)
Reactions: Neuropathy Peripheral, Upper Respiratory Tract Infection, Urinary Tract Infection, Pleural Effusion, Pyrexia, Leukocytosis, Sinusitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Mantle Cell Lymphoma
Cytarabine
Dosage: 1.87 g, cyclic
Indication: Mantle Cell Lymphoma
Dexamethasone
Dosage: 40 mg, unk
Administration route: Oral
Indication: Mantle Cell Lymphoma
Doxorubicin Hydrochloride
Dosage: 50 mg/m2, unk
Indication: Mantle Cell Lymphoma
Mesna
Dosage: 600 mg/m2, unk
Indication: Mantle Cell Lymphoma
Methotrexate
Indication: Mantle Cell Lymphoma
Rituximab
Dosage: 1 mg/m2, cyclic
Indication: Mantle Cell Lymphoma
Velcade
Dosage: 0.7 mg/m2, cyclic
Start date: 2012-03-19
Velcade
Dosage: 2.77 mg, cyclic
Indication: Mantle Cell Lymphoma
Start date: 2011-12-31
Velcade
Dosage: 0.7 mg/m2, cyclic
Velcade
Dosage: 0.7 mg/m2, cyclic
Start date: 2012-02-26
Vincristine
Dosage: 2 mg, cyclic
Indication: Mantle Cell Lymphoma
Other drugs received by patient: Sennosides A+B; Nystatin; Diphenhydramine Hydrochloride; Neupogen; Fluconazole; Zofran; Valtrex; Sodium Chloride; Meperidine HCL; Potassium Chloride; Leucovorin Calcium; Zofran; Sodium Chloride; Sodium Chloride; Sodium Chloride; Heparin; Leucovorin Calcium; Allopurinol; Lovenox; Morphine; Senokot; Cipro / 00042702 /; Lovenox; Prednisolone Acetate; Stomatologicals, Mouth Preparations; Tramadol; Sodium Bicarbonate
Possible Cytarabine side effects in
Reported by a physician from United States on 2012-08-16
Patient:
Reactions: Off Label Use, Hypernatraemia
Drug(s) suspected as cause:
Asparaginase
Dosage: 2500 units/m2/dose
Indication: Acute Lymphocytic Leukaemia
Bortezomib
Dosage: on days 1, 4, 8, and 11
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: day 1
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: divided into 2 doses was given orally for 14 consecutive days.
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: over 15-30 minutes on day 1
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: day 1
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: (2 mg maximum dose) was administeredintravenously by push day 1, 8, 15, and 22
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Voriconazole; Posaconazole; Levofloxacin; Vancomycin
Possible Cytarabine side effects in
Reported by a physician from United States on 2012-08-16
Patient:
Reactions: Off Label Use, Hypoxia, Bacterial Sepsis
Drug(s) suspected as cause:
Bortezomib
Dosage: push on days 1, 4, 8, and 11
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: day 1 with no cns involvement + on days 8, 15 + 22 with cns involvement
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: divided into 2 doses for 14 consecutive days from day 1
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: over 15-30 minutes on day 1
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: who had no cns involvement- day 15;
Indication: Acute Lymphocytic Leukaemia
PEG-Asparaginase
Dosage: pegylated 2500 units/m2/dose given intravenously as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: by push (2 mg maximum dose) was administered intravenously by push day 1, 8, 15, and 22
Indication: Acute Lymphocytic Leukaemia
Possible Cytarabine side effects in male
Reported by a physician from Netherlands on 2012-08-16
Patient: male, weighing 66.0 kg (145.2 pounds)
Reactions: Bronchopulmonary Aspergillosis, Dyspnoea, Respiratory Failure, Sepsis, Hepatic Lesion
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 18.48 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-07-03
Cytarabine
Dosage: 369.66 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-07-03
Idarubicin HCL
Dosage: 22.18 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-07-03
Other drugs received by patient: Piperacillin W
Possible Cytarabine side effects in
Reported by a physician from United States on 2012-08-16
Patient:
Reactions: Off Label Use, Amylase Abnormal, Lipase Abnormal
Drug(s) suspected as cause:
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: on day 1 over 15-30 minutes
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Possible Cytarabine side effects in 50 year old male
Reported by a physician from Germany on 2012-08-16
Patient: 50 year old male, weighing 73.0 kg (160.6 pounds)
Reactions: Neutropenic Colitis, Pneumonia
Drug(s) suspected as cause:
Atracurium Besylate
Dosage: 90 mg, unk
Start date: 2012-07-25
Cytarabine
Dosage: 188 mg, unk
Start date: 2012-07-19
End date: 2012-07-24
Etoposide
Dosage: 188 mg, unk
Start date: 2012-07-19
End date: 2012-07-21
Idarubicin HCL
Dosage: 22.56 mg, unk
Start date: 2012-07-19
End date: 2012-07-24
Page 1 Next >>
|
